Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, agonists |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), NIACR1 agonists(Hydroxycarboxylic acid receptor 2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingIND Application |
First Approval Date- |
Regulation- |
Molecular FormulaC6H6N2O3 |
InChIKeyDJQOOSBJCLSSEY-UHFFFAOYSA-N |
CAS Registry51037-30-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipidemia, Familial Combined | IND Application | China | 24 Mar 2006 | |
Hyperlipidemia, Familial Combined | IND Application | China | 24 Mar 2006 |